Assessing the Value for Money of Enzyme Replacement Therapy in Gaucher Disease Types 1 and 3b: Can Expanded Coverage Be Justified?
评估戈谢病 1 型和 3b 型酶替代疗法的性价比:扩大覆盖范围是否合理?
期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-025-00579-x
Rattanavipapong, Waranya; Anothaisintawee, Thunyarat; Isaranuwatchai, Wanrudee; Wattanasirichaigoon, Duangrurdee; Tim-Aroon, Thipwimol; Wichajarn, Khunton; Sathienkijkanchai, Achara; Charoenkwan, Pimlak; Suphapeetiporn, Kanya; Traivaree, Chanchai; Kuptanon, Chulaluck; Teerawattananon, Yot